News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
acuerdo Bioeurope
Caszyme and Integra Therapeutics sign licensing agreement for novel CRISPR Cas12l nucleases
Healthcare · Advanced therapies
The agreement was unveiled at this year’s BIO Europe, which is the largest partnering event for the…
Green Innovation Forum 2024
The Green Innovation Forum 2024 Will analyze the key role of biotechnology in the transition towards a more sustainable economy in Pamplona
Climate change · Agrifood · Food & feed · Agriculture · Bioeconomy
The Green Innovation Forum 2024 is a must-attend event for companies, foundations, and academic…
inverstors day
Mikrobiomik celebrates the first Investor's Day: presents clinical and corporate progress
Communication · Talento · Corporate
El pasado 24 de octubre, Mikrobiomik celebró su primer Investor´s Day, reuniendo a profesionales…
imagen
ProtoQSAR presents new advances in computational toxicology research with scientific publications on chemical risk assessment, hepatotoxicity, and nanomaterials.
Industrial biotechnology
noticia bcn health
BCN HEALTH publishes a study evaluating the costs due to productivity losses associated to leukaemia in Spain
Healthcare · Access to innovation
menarini y igtp
Menarini and the Germans Trias i Pujol Research Institute sign an agreement to promote research projects
Healthcare · Access to innovation
The organisations are collaborating on two studies in the field of severe Legionella infections and…
inbrain
INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology
Healthcare · Access to innovation · Innovative drugs
VC funding led by imec.xpand, with significant participation from the EIC Fund (venture arm of the…
sede oryzon
ORYZON reports financial results and corporate update for quarter ended September 30, 2024
Healthcare · Advanced therapies · Financing
Final data from PORTICO, global Phase IIb vafidemstat trial in BPD,presented at the 37th ECNP…
resultados Admit Therapeutics
ADmit Therapeutics predicts progression to Alzheimer's dementia 14 years in advance
Healthcare · Advanced therapies